ABSTRACT Although the use of pressurised aerosol inhalers is widespread, little is known about the actual deposition of the aerosol in the respiratory tract, since this has previously been difficult to measure. We have incorporated Teflon particles (mean various conditions and for assessment of theracentages of the dose deposited on the conducting airways and in the alveoli are unknown. In this paper we present the first direct measurement of the deposition of pressurised inhalation aerosols, using an objective in vivo radioactive technique.
Since the identification of specific 62 receptors in the human respiratory tract,' selective sympathomimetic bronchodilator aerosols have been in common use for the treatment of asthma. Pressurised canisters are a portable and convenient means of administering these and other aerosols. In spite of this widespread use, relatively little is known about the deposition of pressurised aerosols in the respiratory tract. Because of the delivery mechanism of pressurised aerosols, involving large propellant droplets travelling initially at very high velocities,2 previously published measurements of aerosol deposition during quiet breathing3 4 are inapplicable. Attempts to estimate deposition of pressurised aerosols have almost always been indirect because of difficulties in labelling the aerosol particles with a suitable radioisotope. Studies based upon the plasma levels of bronchodilators and their metabolites after oral and inhaled doses have suggested that the majority (80%) of the bronchodilator dose is deposited in the mouth and subsequently swallowed and that only 10% reaches the lung directly.5 6 As these figures are only approximate and give no indication of the deposition pattern within the lung, the per-various conditions and for assessment of theracentages of the dose deposited on the conducting airways and in the alveoli are unknown. In this paper we present the first direct measurement of the deposition of pressurised inhalation aerosols, using an objective in vivo radioactive technique.
Methods
In order to study the deposition of pressurised aerosols, we have incorporated Teflon particles (density 2'1 gm cm-3), generated by the spinning disc technique,7 into metered-dose inhalers. A fine suspension of fluorocarbon resin (Teflon 120, Dupont) in a mixture of 40% ethanol and 99mtech-netium (Tc) was delivered to the centre of the rapidly rotating disc. The particles generated (mean diameter 2 ,tm, standard deviation 0 4 ,tm) were allowed to settle onto the base of a large airtight tank inside which the generator was situated. After collection, the 99mTc was firmly sealed within the particles by heating at 2400C for five minutes.
The pressurised canisters and valves used in this study were A dual detector probe system,'1 collimated so as to include most of both lungs but to exclude the stomach, was used to count the lung deposit shortly after inhalation and then 24 h later. The fraction of the initial lung burden present at 24 h, corrected for radioactive decay, was used as a measure of alveolar deposition of inhaled Teflon particles. 4 12 Each patient gave informed consent in writing, and the studies were approved by the Ethical Practices Committee of the Hospital.
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Results
The mean percentages of the dose deposited at various sites are summarised in fig 2, and a typical gamma camera picture of the head, chest, and stomach of one patient shortly after inhalation is shown in fig 3. In eight patients, the mean percentage of the dose deposited in the lungs was 8-8% (SD 3 4%, range 4'7-14-8%) of which 3-0+ 3-1% (mean+4SD) was deposited in the alveoli and 5-8+-2-6% on the conducting airways. The percentage of the dose initially deposited in the mouth was 80-4-+-60% (range 70-2-89 1%). The remainder of the dose was deposited in the aerosol actuator (mean 9-8% of dose) or was recovered from the expired air (mean 1 0% of dose). The aerosol canister was fired at 21+4% vital capacity during the course of a rapid inhalation (average flow rate 67.2420.3 1 min-', maximum flow rate 127 2+43-6 1 min-'). The breath-holding pause after inhalation was 3 9+0 2 seconds. 
Discussion
These results confirm the findings of earlier indirect studies5 6 
